PolyActiva expands Executive Team to drive transformational growth and advance late-stage clinical development in the US

PolyActiva has expanded their Executive Team, appointing Wes Brazell as Chief Financial Officer, and Michael Brubaker, PhD, as Chief Scientific Officer. Their appointments come at an important time for the…

Continue ReadingPolyActiva expands Executive Team to drive transformational growth and advance late-stage clinical development in the US